azacitidine and Bone Loss, Osteoclastic

azacitidine has been researched along with Bone Loss, Osteoclastic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fang, Z; Guan, H; Li, F; Li, J; Li, Y; Mi, B; Tan, P; Wu, W; Zhang, Y1
Kobyliansky, E; Mizrahi, L; Savion, S; Shahar, R; Toder, V; Torchinsky, A1

Other Studies

2 other study(ies) available for azacitidine and Bone Loss, Osteoclastic

ArticleYear
Decitabine represses osteoclastogenesis through inhibition of RANK and NF-κB.
    Cellular signalling, 2015, Volume: 27, Issue:5

    Topics: Animals; Azacitidine; Bone Resorption; Cell Differentiation; Cell Line; Cells, Cultured; Decitabine; DNA Methylation; DNA Modification Methylases; Female; Mice, Inbred C57BL; NF-kappa B; Osteoclasts; RANK Ligand; Signal Transduction; Transcription Factor AP-1

2015
Bone loss in adult offspring induced by low-dose exposure to teratogens.
    Journal of bone and mineral metabolism, 2012, Volume: 30, Issue:3

    Topics: Acid Phosphatase; Aging; Animals; Apoptosis; Azacitidine; Bone Resorption; Embryo, Mammalian; Female; Femur; Gene Expression Profiling; Gene Expression Regulation, Developmental; Hindlimb; Isoenzymes; Limb Buds; Mice; Mice, Inbred ICR; MicroRNAs; Osteoblasts; Osteogenesis; Osteoprotegerin; Pregnancy; Prenatal Exposure Delayed Effects; RANK Ligand; Reproduction; Tartrate-Resistant Acid Phosphatase; Teratogens; X-Ray Microtomography

2012